Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death. Therapeutic options remain very limited and are based on classical chemotherapies. Energy metabolism reprogramming appears as an emerging hallmark of cancer and is considered a therapeutic target with conside...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncogene
Main Authors: Rademaker, Gilles, Hennequière, Vincent, Brohée, Laura, Nokin, Marie-Julie, Lovinfosse, Pierre, Durieux, Florence, Gofflot, Stéphanie, Bellier, Justine, Costanza, Brunella, Herfs, Michael, Peiffer, Raphael, Bettendorff, Lucien, Deroanne, Christophe, Thiry, Marc, Delvenne, Philippe, Hustinx, Roland, Bellahcène, Akeila, Castronovo, Vincent, Peulen, Olivier
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6085282/
https://ncbi.nlm.nih.gov/pubmed/29720728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0287-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares